乐心医疗
(300562)
| 流通市值：29.79亿 | | | 总市值：38.99亿 |
| 流通股本：1.67亿 | | | 总股本：2.19亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 534,432,244.98 | 283,737,915.92 | 986,210,596.57 | 757,129,146.52 |
| 营业收入 | 534,432,244.98 | 283,737,915.92 | 986,210,596.57 | 757,129,146.52 |
| 二、营业总成本 | 467,557,330.98 | 250,558,737.99 | 886,886,005.21 | 685,490,345.42 |
| 营业成本 | 340,418,107.16 | 176,584,878.54 | 635,079,142.63 | 487,684,162.71 |
| 税金及附加 | 5,166,801.31 | 1,886,539.74 | 8,961,737.42 | 5,270,907 |
| 销售费用 | 24,204,396.94 | 18,027,854 | 77,018,249.79 | 62,173,571.68 |
| 管理费用 | 38,764,858.44 | 23,090,151.1 | 69,639,875.89 | 58,034,995.18 |
| 研发费用 | 50,019,146.22 | 26,686,069.37 | 95,104,108.21 | 70,314,459.02 |
| 财务费用 | 8,984,020.91 | 4,283,245.24 | 1,082,891.27 | 2,012,249.83 |
| 其中:利息费用 | 94,724.55 | 37,015.86 | 2,355,028.19 | 3,002,999.71 |
| 其中:利息收入 | 875,503.44 | 330,331.38 | 6,635,100.25 | 4,886,259.94 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -829,661.81 | 1,187,919.68 | 429,539.63 | -137,329.82 |
| 加:投资收益 | 2,559,561.89 | -75,604.92 | 4,786,295.35 | 4,331,584.38 |
| 资产处置收益 | -1,360,492.59 | 53,996.28 | -26,109.1 | -2,769.11 |
| 资产减值损失(新) | -2,716,800.3 | - | -21,056,488.12 | -5,755,914.8 |
| 信用减值损失(新) | -2,441,810.41 | -2,195,383.67 | -2,646,254.78 | -4,969,898.63 |
| 其他收益 | 2,365,643.89 | 695,479.09 | 5,515,283.56 | 3,321,716.79 |
| 四、营业利润 | 64,451,354.67 | 32,845,584.39 | 86,326,857.9 | 68,426,189.91 |
| 加:营业外收入 | 16,615.18 | 43,164.8 | 214,999.78 | 144,782.49 |
| 减:营业外支出 | 364,332.28 | 65,590.33 | 2,196,122.07 | 816,197.34 |
| 五、利润总额 | 64,103,637.57 | 32,823,158.86 | 84,345,735.61 | 67,754,775.06 |
| 减:所得税费用 | 4,767,762.76 | 931,104.49 | 4,076,953.51 | 2,992,615.73 |
| 六、净利润 | 59,335,874.81 | 31,892,054.37 | 80,268,782.1 | 64,762,159.33 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 59,335,874.81 | 31,892,054.37 | 80,268,782.1 | 64,762,159.33 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 60,037,109.36 | 32,073,808.31 | 81,999,096.6 | 65,681,388.28 |
| 少数股东损益 | -701,234.55 | -181,753.94 | -1,730,314.5 | -919,228.95 |
| 扣除非经常损益后的净利润 | 58,963,453.62 | 31,357,459.02 | 76,802,074.54 | 59,617,527.59 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.27 | 0.15 | 0.38 | 0.3 |
| (二)稀释每股收益 | 0.27 | 0.15 | 0.38 | 0.3 |
| 八、其他综合收益 | 59,536,443.27 | -6,631.94 | -12,668,222.99 | -723,961.64 |
| 归属于母公司股东的其他综合收益 | 59,536,443.27 | -6,631.94 | -12,668,222.99 | -723,961.64 |
| 九、综合收益总额 | 118,872,318.08 | 31,885,422.43 | 67,600,559.11 | 64,038,197.69 |
| 归属于母公司股东的综合收益总额 | 119,573,552.63 | 32,067,176.37 | 69,330,873.61 | 64,957,426.64 |
| 归属于少数股东的综合收益总额 | -701,234.55 | -181,753.94 | -1,730,314.5 | -919,228.95 |
| 公告日期 | 2026-08-25 | 2026-04-24 | 2026-04-10 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |